These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33605958)

  • 1. Approaches in metabolomics for regulatory toxicology applications.
    Olesti E; González-Ruiz V; Wilks MF; Boccard J; Rudaz S
    Analyst; 2021 Mar; 146(6):1820-1834. PubMed ID: 33605958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology.
    Harrill JA; Viant MR; Yauk CL; Sachana M; Gant TW; Auerbach SS; Beger RD; Bouhifd M; O'Brien J; Burgoon L; Caiment F; Carpi D; Chen T; Chorley BN; Colbourne J; Corvi R; Debrauwer L; O'Donovan C; Ebbels TMD; Ekman DR; Faulhammer F; Gribaldo L; Hilton GM; Jones SP; Kende A; Lawson TN; Leite SB; Leonards PEG; Luijten M; Martin A; Moussa L; Rudaz S; Schmitz O; Sobanski T; Strauss V; Vaccari M; Vijay V; Weber RJM; Williams AJ; Williams A; Thomas RS; Whelan M
    Regul Toxicol Pharmacol; 2021 Oct; 125():105020. PubMed ID: 34333066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Toxicology Tools and the Emerging Paradigm Shift in Environmental Health Decision-Making.
    Ginsberg GL; Pullen Fedinick K; Solomon GM; Elliott KC; Vandenberg JJ; Barone S; Bucher JR
    Environ Health Perspect; 2019 Dec; 127(12):125002. PubMed ID: 31834829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective.
    van Ravenzwaay B; Montoya GA; Fabian E; Herold M; Krennrich G; Looser R; Mellert W; Peter E; Strauss V; Walk T; Kamp H
    Toxicol Lett; 2014 May; 227(1):20-8. PubMed ID: 24657160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: toxicometabolomics.
    Bouhifd M; Hartung T; Hogberg HT; Kleensang A; Zhao L
    J Appl Toxicol; 2013 Dec; 33(12):1365-83. PubMed ID: 23722930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics in Preclinical Drug Safety Assessment: Current Status and Future Trends.
    Sillé F; Hartung T
    Metabolites; 2024 Jan; 14(2):. PubMed ID: 38392990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics in chemical risk analysis - A review.
    Hernández-Mesa M; Le Bizec B; Dervilly G
    Anal Chim Acta; 2021 Apr; 1154():338298. PubMed ID: 33736812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR.
    van Ravenzwaay B; Herold M; Kamp H; Kapp MD; Fabian E; Looser R; Krennrich G; Mellert W; Prokoudine A; Strauss V; Walk T; Wiemer J
    Mutat Res; 2012 Aug; 746(2):144-50. PubMed ID: 22305969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics in toxicology and preclinical research.
    Ramirez T; Daneshian M; Kamp H; Bois FY; Clench MR; Coen M; Donley B; Fischer SM; Ekman DR; Fabian E; Guillou C; Heuer J; Hogberg HT; Jungnickel H; Keun HC; Krennrich G; Krupp E; Luch A; Noor F; Peter E; Riefke B; Seymour M; Skinner N; Smirnova L; Verheij E; Wagner S; Hartung T; van Ravenzwaay B; Leist M
    ALTEX; 2013; 30(2):209-25. PubMed ID: 23665807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating legacy contaminants and emerging chemicals in marine environments using adverse outcome pathways and biological effects-directed analysis.
    Hutchinson TH; Lyons BP; Thain JE; Law RJ
    Mar Pollut Bull; 2013 Sep; 74(2):517-25. PubMed ID: 23820191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of chemicals in Sweden: an example of misuse of the "precautionary principle".
    Nilsson R
    Ecotoxicol Environ Saf; 2004 Feb; 57(2):107-17. PubMed ID: 14759655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems toxicology: from basic research to risk assessment.
    Sturla SJ; Boobis AR; FitzGerald RE; Hoeng J; Kavlock RJ; Schirmer K; Whelan M; Wilks MF; Peitsch MC
    Chem Res Toxicol; 2014 Mar; 27(3):314-29. PubMed ID: 24446777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MutAIT: an online genetic toxicology data portal and analysis tools.
    Avancini D; Menzies GE; Morgan C; Wills J; Johnson GE; White PA; Lewis PD
    Mutagenesis; 2016 May; 31(3):323-8. PubMed ID: 26208916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use cases, best practice and reporting standards for metabolomics in regulatory toxicology.
    Viant MR; Ebbels TMD; Beger RD; Ekman DR; Epps DJT; Kamp H; Leonards PEG; Loizou GD; MacRae JI; van Ravenzwaay B; Rocca-Serra P; Salek RM; Walk T; Weber RJM
    Nat Commun; 2019 Jul; 10(1):3041. PubMed ID: 31292445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.